<code id='DFF2FABD34'></code><style id='DFF2FABD34'></style>
    • <acronym id='DFF2FABD34'></acronym>
      <center id='DFF2FABD34'><center id='DFF2FABD34'><tfoot id='DFF2FABD34'></tfoot></center><abbr id='DFF2FABD34'><dir id='DFF2FABD34'><tfoot id='DFF2FABD34'></tfoot><noframes id='DFF2FABD34'>

    • <optgroup id='DFF2FABD34'><strike id='DFF2FABD34'><sup id='DFF2FABD34'></sup></strike><code id='DFF2FABD34'></code></optgroup>
        1. <b id='DFF2FABD34'><label id='DFF2FABD34'><select id='DFF2FABD34'><dt id='DFF2FABD34'><span id='DFF2FABD34'></span></dt></select></label></b><u id='DFF2FABD34'></u>
          <i id='DFF2FABD34'><strike id='DFF2FABD34'><tt id='DFF2FABD34'><pre id='DFF2FABD34'></pre></tt></strike></i>

          fashion

          fashion

          author:hotspot    Page View:23
          People waiting in line, standing in between red rope. -- first opinion coverage from STAT
          Adobe

          Health care providers and health insurance companies are closing the books on their third quarters, and one major question continues to hang over them: How much care is everyone actually getting, now that Covid-19 isn’t scaring so many away from doctors and hospitals?

          The short answer, according to financial analysts and the companies themselves: It appears people continue to fill prescriptions, see their doctors, and get recommended surgeries.

          advertisement

          For health insurers, those trends mean they will have to deposit more money into the bank accounts of providers — perhaps more than they predicted.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more
          Novo Nordisk to expand supply of Wegovy for U.S. patients
          Novo Nordisk to expand supply of Wegovy for U.S. patients

          BloombergphotobyGeorgeFreyLONDON—NovoNordisksaidWednesdaythatithadstartedtoincreasetheavailabilityof

          read more
          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more

          Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

          CraigF.Walker/TheBostonGlobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togeto